Back to Journals » Drug Design, Development and Therapy » Volume 12

Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study

Total article views   Abstract views HTML views PDF downloads Totals
4,728 Dovepress* 4,519 138+ 154 4,657
PubMed Central* 0 71 22 71
Totals 4,519 209 176 4,728
*Since 19 December 2018
+Since July 2016

View citations on PubMed Central and Google Scholar